Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Among all 34 subjects, there was an overall association between decrease in PGA and improvement in serum 25(OH)D after supplementation.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Full studies
Change in disease activity after vitamin D supplementation in children with systemic lupus erythematosus and juvenile dermatomyositis
Study design awaiting verification · Pediatric Rheumatology Online Journal · 2012
Original publication title
Change in disease activity after vitamin D supplementation in children with systemic lupus erythematosus and juvenile dermatomyositis
Copyright ©2012 Robinson et al; licensee BioMed Central Ltd.
Original publication · Publisher record · CC BY 2.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What objectives does the paper state?
Recent studies have implicated low vitamin D levels with greater disease activity in pediatric systemic lupus erythematosus (SLE) and we have reported an association between low vitamin D levels and greater disease activity in juvenile dermatomyositis. The objective of this study was to explore whether standardized vitamin D supplementation of low levels of 25-hydroxyvitamin D [25(OH)D] might be associated with improvements in disease activity.
Source: PurposeStudy methods
What methods does the paper describe?
Subjects diagnosed with JDM or SLE prior to the age of 18 were consented and given a questionnaire regarding demographics, sunscreen use, and dietary habits to assess conventional risk factors for vitamin D deficiency. Serum 25(OH)D was determined. Disease activity was rated using a 10-cm physician’s global assessment (PGA) in all subjects and a SLE disease activity index (SLEDAI) in subjects with SLE. All subjects with serum 25(OH)D levels less than 30ng/mL were given ergocalciferol 50,000 IU weekly for 8 weeks, and serum 25(OH)D levels, PGA, and SLEDAI were reevaluated at their next routine follow up visit.
T-tests and linear regression were used to examine the association between change in PGA or SLEDAI with change in serum 25(OH)D levels after supplementation.
Source: MethodsSupport
Duke Children’s Miracle Network.
Mean change in disease activity compared by serum 25-hydroxyvitamin D sufficiency or insufficiency after treatment
| Follow up 25(OH)D < 30 ng/mL | Follow up 25(OH)D >= 30 ng/mL | p-value | |
|---|---|---|---|
| Overall mean change in PGA (n=34) | 0.1 cm | -1.6 cm | 0.08 |
| Mean change in PGA among SLE (n=23) | 0.2 cm | -0.6 cm | 0.47 |
| Mean change in PGA among JDM (n=11) | -0.2 cm | -3.0 cm | 0.15 |
| Mean change in SLEDAI (n=23) | -1.6 | -4.3 | 0.36 |
Results
There were 58 subjects; 21 with JDM and 37 with SLE. At baseline, 31/37 or 84% of subjects with SLE had serum 25(OH)D < 30 ng/mL, and 13/21 or 62% of subjects with JDM had serum 25(OH)D < 30 ng/mL. 23 subjects with SLE and 11 subjects with JDM had followup serum 25(OH)D levels and disease activity scores available for analysis. Among all 34 subjects, there was an overall association between decrease in PGA and improvement in serum 25(OH)D after supplementation.
For every 1 point improvement in 25(OH)D, there was a mean decrease in PGA by 0.07 cm (95% CI 0.01-0.13cm) (p = 0.02). Looking independently at subjects with SLE and JDM, there was a trend towards an association between decreased PGA or SLEDAI and better response to supplementation, but these associations were not significant.
Source: ResultsConclusion
Results are suggestive that there may be an improvement in disease activity associated with better response to vitamin D supplementation in children with SLE and JDM. This pilot study can be used only for hypothesis generation; it is underpowered to look at possible confounding by other medications or other factors, but suggest that a larger study to look prospectively at the effect of vitamin D supplementation on disease activity in these two diseases is warranted.
Source: ConclusionAuthors’ abstract
Read the full paper
Purpose
Recent studies have implicated low vitamin D levels with greater disease activity in pediatric systemic lupus erythematosus (SLE) and we have reported an association between low vitamin D levels and greater disease activity in juvenile dermatomyositis. The objective of this study was to explore whether standardized vitamin D supplementation of low levels of 25-hydroxyvitamin D [25(OH)D] might be associated with improvements in disease activity.
Methods
Subjects diagnosed with JDM or SLE prior to the age of 18 were consented and given a questionnaire regarding demographics, sunscreen use, and dietary habits to assess conventional risk factors for vitamin D deficiency. Serum 25(OH)D was determined. Disease activity was rated using a 10-cm physician’s global assessment (PGA) in all subjects and a SLE disease activity index (SLEDAI) in subjects with SLE. All subjects with serum 25(OH)D levels less than 30ng/mL were given ergocalciferol 50,000 IU weekly for 8 weeks, and serum 25(OH)D levels, PGA, and SLEDAI were reevaluated at their next routine follow up visit.
T-tests and linear regression were used to examine the association between change in PGA or SLEDAI with change in serum 25(OH)D levels after supplementation.
Results
There were 58 subjects; 21 with JDM and 37 with SLE. At baseline, 31/37 or 84% of subjects with SLE had serum 25(OH)D < 30 ng/mL, and 13/21 or 62% of subjects with JDM had serum 25(OH)D < 30 ng/mL. 23 subjects with SLE and 11 subjects with JDM had followup serum 25(OH)D levels and disease activity scores available for analysis. Among all 34 subjects, there was an overall association between decrease in PGA and improvement in serum 25(OH)D after supplementation.
For every 1 point improvement in 25(OH)D, there was a mean decrease in PGA by 0.07 cm (95% CI 0.01-0.13cm) (p = 0.02). Looking independently at subjects with SLE and JDM, there was a trend towards an association between decreased PGA or SLEDAI and better response to supplementation, but these associations were not significant.
Conclusion
Results are suggestive that there may be an improvement in disease activity associated with better response to vitamin D supplementation in children with SLE and JDM. This pilot study can be used only for hypothesis generation; it is underpowered to look at possible confounding by other medications or other factors, but suggest that a larger study to look prospectively at the effect of vitamin D supplementation on disease activity in these two diseases is warranted.
Support
Duke Children’s Miracle Network.
Mean change in disease activity compared by serum 25-hydroxyvitamin D sufficiency or insufficiency after treatment
| Follow up 25(OH)D < 30 ng/mL | Follow up 25(OH)D >= 30 ng/mL | p-value | |
|---|---|---|---|
| Overall mean change in PGA (n=34) | 0.1 cm | -1.6 cm | 0.08 |
| Mean change in PGA among SLE (n=23) | 0.2 cm | -0.6 cm | 0.47 |
| Mean change in PGA among JDM (n=11) | -0.2 cm | -3.0 cm | 0.15 |
| Mean change in SLEDAI (n=23) | -1.6 | -4.3 | 0.36 |
Disclosure
Angela B. Robinson: None; Eveline Y. Wu: None; Egla C. Rabinovich: None.
Publication and source details
Original title: Change in disease activity after vitamin D supplementation in children with systemic lupus erythematosus and juvenile dermatomyositis
Angela B Robinson; Eveline Y Wu; Egla C Rabinovich
Pediatric Rheumatology Online Journal · 2012
Copyright ©2012 Robinson et al; licensee BioMed Central Ltd.2012Robinson et al; licensee BioMed Central Ltd.https://creativecommons.org/licenses/by/2.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T21:12:55.445716+00:00
DOI: 10.1186/1546-0096-10-s1-a13 · PMC3403088